ESTRO Brachytherapy for Prostate Cancer 2018

705 / 884

best candidate
• histologically verified recurrent prostate cancer
• neg. CT scan and skeletal scintigraphy
• PSADT> 12 months
• PSA < 15ng/ml
• bladder capacity > 300ml, competent sphincter, no bladder
neck invasion